Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
Hawkhead virtually every argument you have put put up against Fum has been defeated by every other poster on this forum many times over, as you keep saying over and over again “ you just don’t get it. “. You’ve lost your money now move on , and enjoy Xmas and the massive jump in fums shares, because I am .
GLA
Hawkhead save yourself time and money and ring these people, Samaritans 116123. and Free 24/7
I have a feeling they might even know you.
GLA
Also please bear in mind the massive changes in people’s buying patterns, people are researching what their own condition are, and needs, and simply and quickly ordering what they need online from the online prescription doctors, I can’t emphasise this enough, people are making there own appointments with their own GP’s online, ordering there own prescriptions from their surgeries online, so believe me this wait for the OTC market is a rapidly changing market, who wants to wait for a GP’s appointment when can bypass your own GP and simply get a prescription for our med gel online, that’s why I’m trying to emphasise the importance of the rapidly changing buying patterns of ERECTILE DYSFUNCTIONAL consumers , and also just ordinary online buying .
If our med gel was available on prescription right now, I could purchase it online right now standing right here in the middle of this sunday morning market I’m at. It’s that simple, that means the prescription MARKET is no barrier to buying our med gel. Just think how many shops are closing because of online buying, it’s all changing rapidly,
And that means the buying of our med gel could increase substantially every year it’s on sale.
The futures bright and It’s a rapidly changing online environment, and we are going to reap the huge rewards from that change.
Good luck all
Our 30% placebo effect will fall to or below the industry norm of 25% , this is a given placebo trial result, and it's widely expected. Viagra users don't physically arouse themselves minutes after taking the tablet, our trial participants do, so is it any surprise that the lines of the placebo effect get increased , but as I've already said this will drop to the normal placebo effect using 1000 trial participants.
Forget about viagra, we're initially targeting people who viagra can't treat at ll, because they are contraindicated, and anyone else is a massive financial bonus.
Incredible potential here. The futures bright , our med gel will be a household name in a few years time.
Good luck ALL
Nice calculations tomboytheone ,
The first dilution seemed awful, though critically necessary, the upside is so good we can easily absorb a reasonable fund raising, the first one was robbery, though in fairness we all had the opportunity to seriously average our holdings downwards
But in fairness to us we were all so stunned at the low SP and how much our own holdings were worth , that most of us feared buying any more of the shares, I didn't buy in again until it was 14p. We can take these funding hits because the upside four potential be massive, or just reasonable, either way, it still looks like a low risk investment that could easily multiply our money many times over.
The med gel works ok, that's been proven and validated by 200 leading erectile dysfunctional urologist from around the world,
If our efficacy increases , then the number of urologist that would prescribe our med gel would increase exponentially, and more importantly as a safe First line of ED treatment.
Why would that happen,? Because these urologist are as far as I've read, reluctantly prescribing millions of other treatments that don't Safely address the ED problems, our med gel is genuinely a superior treatment to all these other treatments, even viagra can't do what our med gel does, that's impossible, 5/10minute erection time, our safety profile leaves viagra behind,
Our MED GEL will destroy vitaros , nobody in there right mind wants to inject a greasy cream down into the urethra via the sphincter to attain a erection, but seemingly patients have no other choice but to use this plastic syringe to inject this concoction, would they not wish to use a clear clean non greasy gel, easily and quickly absorbed , and giving a erection 5/10 minutes later, and with little or no transference to one's partner, and it seems that a very large percentage of our med gel trial participants are getting our med gel applied by there sexual partners in foreplay, that's exactly what we wanted, this proves our med gel has a very ease of usage by both trial participants, and believe me that's a truly massive endorsement for our med gels Likability and usage.
There is so many plusses for our med gel , that it's quite easy to see that it will be prescribed and sold worldwide in vast amounts, if something as horrible as vitaros can be sold in vast amounts, then how quickly can we take this market . I truly mean this, there's absolutely nothing that even comes close to what our med gel does, in safety and efficacy.
People will carry both viagra and our med gel , depending on the situation, drink / drunk drinkers droop, over eating etc, our med gel is a great we insurance policy for all occasions. The futures bright , the futures is our fantastic we med Gel.
Good luck ALL
https://www.jefferies.com/IdeasAndPerspectives/Conferences/325/112019
It's over 2 days , so time wise it's possible, though we would rightfully get a RNS first from fum, to show us all the assimilated data of our 3rd trials findings, that could happen ok if they work their socks of collating everything quickly enough, and wouldn't it be a fantastic thing to present at Jefferies conference, the extra commercial interest that would generate would be significant , elements of the world's press should be there . It makes fantastic commercial sense for that to happened.
Let's cross our fingers.
Good luck ALL
Azurite you wouldn't happen to have a few shares in faron pharmaceutical, and now your doing a we bit of ramping up other investors to buy your faron shares, ? I'M ok with that, food for thought, though I Genuinely don't like farons risk, I in the past watched a big £2 billion pharmaceutical company collapse to zero after its long awaited cancer treatment completely failed,
That was a absolute shocker to witness, luckily I'd no shares in it. Buyer beware, fums MED gel is a completely different type of risk, it's incredibly low , but only in my opinion. DYOR BEFORE BUYING.
Good luck all.
Fantastic Hawkhead you’ve literally just answered all 10 of your own questions .
= you really just don’t get it do you.
GLA
Hawkhead make sure you pay all that money back to your granny now. Talk about hedging you’re imaginary bets LOL .
Anything that converts into Stirling will do me, with the amount of negotiations that’s went on over the last few years, I’m feel that all the ground work is in place with our licensing suitors, they know what we want ok, and our 3rd trial results can pave the way for that long awaited highly de-risk ED GEL , and also that extra 50% increase in value of our med gels worth. The problem could come if other big pharmaceutical companies start knocking at our door to trump and better a nearing licensing deal, and delaying things, ie trial cost funding etc. That’s possible, in that case Fum I feel would slowly borrow funding on the strength of that big potential licensing deal. Our med gel is unique and there’s nothing like it or better than it out there, so we should be sitting in a great position to negotiate a fantastic licensing deal.
GLA
As I've said before fum won't be pushed into signing the rights away of our med gel , as JB has stated before we have to fight for the right deal that reflects the huge potential of our med gel, and sometimes it's better waiting after a 3rd trials de-risk results to get the best licencing deal going. And that is exactly what's going to happen. A large upfront payment or our new licencing partner paying for all or most of our second 3rd trial. Plus substantial milestone payments. It all looking fantastic from were I'm sitting. Though it's the stock market ,any thing at all can happen. Up and to a large takout offer.
GLA.
The FDA in America refused vitaros because of its active ingredients of 2.5% of DDAIP .HCI , the FDA wanted it reduced substantially on safety grounds , and that meant it wouldn't give a erection at all , so it left the product useless, there's literally nothing that can be done with it without that 2.5% dosage. I'm genuinely astounded how anyone could use this product, the application and side effects are scary, I would honestly say that even without my investment in fum.
GLA
Martinelwick please do your own research on our med gel, and compare it to the vitaros cream, and you tell me which one you would prefer, and make sure you find out why the American regulators refused it's use on American soil. I'm still astounded why any country would clear this product for use, https://www.drugs.com/nda/vitaros_180216.html
Vitaros greasy oily difficult to use, substantial side effects compared to our med gels use, it's effectiveness has a substantially lower ERECTION success rate than our med gel/ our med gel is easily absorbed, little or no residue left after application, the quickest action of any ED product in the world, the highest erection rate of any topical medication thus far,
So please believe me our med gel is objectively looking at both products the best in its class by a very substantial margin.
But as I've stated before make your own mind up and DYOR, I'm quietly confident we can take most of this market away from anything out there.
GLA
https://www.rttnews.com/1965066/apricus-takeda-enter-into-license-agreement-to-market-vitaros-in-uk.aspx?refresh=1
Sorry I thought I had posted the above link in my last post, I've no idea how that happened, this kindle is seriously faulty, constantly changing what I'm intending to write and post .
GLA
https://www.theguardian.com/world/2018/jul/24/eleven-babies-die-dutch-women-viagra-drug-trial
Vitarios is one of the ED treatments that will be nearly disgarded when our med gel hits the shelves,
It has genuinely terrible side effects, read for yourselves, it's greasy, stains clothing, difficult to use, and has a very questionable regulatory safety profile, it was refused regulatory clearance several times by the American authorities, because they felt it had to dangerous of a active ingredients in it, and when it's active ingredients was reduced to a safer level, it left it's efficacy dysfunctional, / it didn't work , it's makers have up on trying to get it passed in America, but somehow it had been cleared in europe, which beggars belief in my opinion.
Japanese company Takeda a major pharmaceutical company with £384 million profit per year licenced it from apricus bioscience. With undisclosed upfront payment, and milestone payments of up to €35m, euro.
Takeda has spent £42.8 billion buying out SHIRE pharmaceutical.
Is it possible that Japanese based Takeda is interested in our MED GELS licencing deal to especially protect its interest in its financial layout of its licencing deal with Apricus and it's vitarios cream, after all we are sure to clear it's vitarios product of the shelves, it's in my opinion a very serious contender. Especially as it will cost Takeda when we take this market. And we will ok, just study VISTARIOS and you'll understand very quickly WHY I'm saying this. It's a nightmare of a product,
Takeda is also right now disposing of parts of its business to raise money, probably to help with the purchase of SHIRE Pharmaceutical, because of that , I think it more likely they would want a licencing deal than a buyout.That makes good common sense. Though I just can't see there being no stiff , pardon the pun, competition for our med gel licencing deal.
Now that should ensure a premium for our licencing deal at the 3rd trial stage
If I was to bet on a licencing participant, then Takeda would be my number one licencing suitor. If apricus gets a deal like that for a very questionable ED product, which was rightfully refused regulatory clearance in America, how great a deal could we get Then ?. A Fantastic deal comes to mind. The futures bright , and a big deal will be in the making very soon.
Good Luck All
Hawkhead & Zwartkops 2 separate LSE Identities/ names being used by only 1 person.
https://www.theguardian.com/world/2018/jul/24/eleven-babies-die-dutch-women-viagra-drug-trial
Hawkhead your back from hiding after costing investors a fortune, and you've no shame, you told everyone to sell at 25p and they could have sold at 29 + p, and not one apology in sight, have you no shame man.
You come back with a comical story about you having a mate , don't make me laugh hawhead, the rest of that story is farcical, and doesn't even deserve a reply, so I'll leave it at that,
Hawkhead share your views with your bathroom mirror, I'm sure it will steam up quickly enough, there's enough hot air in your lungs to turn your bathroom into a sauna.
I would have more respect for you if you even apologised to the people you told to sell their shares, and cost them a fortune.
It will be a poor Xmas for them now. Why don't you borrow some money and buy some fum shares and you to can have a fantastic rewarding Xmas . I'll lend you a fiver.
Good luck all, apart from the obvious.
Futura medicals long chart prices 36.2p+ 41p+ 78.4p. Now where's Hawkheads disgraceful strong sell rubbish ,and announcements , absolute utter rubbish of a strong sell from Hawkhead , as I've said time and time again ,listen to Hawkhead at your peril and cost. De-rampers the scrounge of these forums, send them packing with your personal opinion on them .
GOOD LUCK ALL. The only way is up .
Fums share price and predictions can make any of us look foolish from one minute to another, LOL,
The reason I thought the share price is so cheap , is because if the 3rd trial goes as planned, then Liberums £137p price target is so much more higher than the current 26p buying price , I know nobody knows right now how our funding will impact our SP ,and especially after the last funding fiasco. Though we must now factor in the imminent / less than a few months before our 3rd trials results get revealed, these results should give us that de-risk and 100% royalty fee and upfront licencing payments. Factor all that in and tell me we're not cheap compared to Liberums £137p price target.
I know what I'm confident about ok, that is our MED GEL will get the green light before Xmas, just one chance in 20 to fail going to market. That's fantastic odds in anyone's books.
When we get the green light with our 3rd trials results, does anyone really think Simon Thompson won't shout from the rooftops about our MED gels future prospects and a £137p liberums target price. I Genuinely have no doubts about us being Simon Thompson's favourite share pick for his bargain share portfolio for 2020,,,, WHY?,,, just read his last article on fum in investors chronicle , dated 18 October 2019 .
"Again I state " , it's the stock market anything can happen in this risky game. DYOR.
GOOD LUCK ALL.
T Adams, with Xmas coming up , he might have expensive Xmas gifts to buy ?
With that size of a holding its a tiny sell to him.
As I've said before it's the licencing deal I'm really waiting for, the 3rd trials results will be good or even brilliant, I'm not ruling out a early outright purchase of our med gel by a big pharmaceutical company, a Chinese offer wouldn't surprise me at all, they seem to throw loads of money at these sort of situations, our med gel is a very rare situation , whereby a product could potentially be bought for just a few hundred million pounds , and then it could eventually make Many billions of pounds by its newowners, either way these big pharmaceutical companies will shortly decide our med gels fate.
Please remember something , our med gel was originally designed and positioned to target these contraindicated ED patients,
Who have no other clinically tested medication to use, it's a sitting ready made market , and waiting for our med gel to fill it.
This should in theory give us a minimum revenue stream , and creating a basic company valuation much higher than today's share price indicates. These big pharmaceutical companies should know our med gel will pay them back with a great profit, and only based on the sitting and waiting prescription market alone.
The longer term OTC market is nearly thrown in for free if we're bought out for only a few hundred million pounds.
In my opinion we're ridiculously cheap at today's valuation, though I'm very confident Simon Thompson will come back before Xmas with a very strong buy recommendation but only after the funding gets sorted, we could even be his main 2020 share tip. And if everything gets sorted ok, then I wouldn't be surprised most of the tabloids tipped us for the new year, I'm certainly going to email as Manny of the financial columnist as I can before Xmas, someone has to blow the trumpet for uk industry. Why not us futura medicals own shareholders .
Good luck all